Our Mission Is To Create A New Category Of Therapeutics That Repair The Damage Caused By Devastating Diseases Our Core Innovation Is The Discovery Of A Global Master Regulatorthe Innate Repair Receptorsirr That Produces Cellular And Tissue Repair In Various Disease Statesour Lead Compound In Clinical Developmentcibinetideis Focused On Addressing Unmet Needs In Neuroscience And Diabetes Complicationswe Have Developed An Extensive Peptide Library Of Irr Activatorswith In Vivo Proof Of Concept Efficacy For 10 Unique Compounds And An Extensive Catalogue Of Scientific Literature In Collaboration With Leading Academic Researchers Around The Globe
No conferences found for this company.
| Company Name | Araim Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
